Comparison between Medicap Healthcare IPO and Supreet Chemicals IPO.
Medicap Healthcare IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Supreet Chemicals IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
| Medicap Healthcare IPO | Supreet Chemicals IPO | |
|---|---|---|
| Logo | ![]() | ![]() |
| Issue Category | Mainboard | Mainboard |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE, NSE | BSE, NSE |
| Lead Managers | Aryaman Financial Services Ltd. | IIFL Capital Services Ltd. |
| Registrar | Kfin Technologies Ltd. | MUFG Intime India Pvt.Ltd. |
| Market Maker | ||
| DRHP | DRHP ![]() | DRHP ![]() |
| RHP | ||
| Final Prospectus | ||
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Medicap Healthcare IPO is up to ₹240.00 Cr whereas the issue size of the Supreet Chemicals IPO is up to ₹499.00 Cr. The final issue price of Medicap Healthcare IPO is and of Supreet Chemicals IPO is .
| Medicap Healthcare IPO | Supreet Chemicals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹2 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 0 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹240.00 Cr | up to ₹499.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 0 shares | 0 shares |
| Issue Size Total (Amount) | up to ₹240.00 Cr | up to ₹499.00 Cr |
Medicap Healthcare IPO opens on , while Supreet Chemicals IPO opens on . The closing date of Medicap Healthcare IPO and Supreet Chemicals IPO is , and , respectively.
Medicap Healthcare IPO P/E ratio is , as compared to Supreet Chemicals IPO P/E ratio of .
| Medicap Healthcare IPO | Supreet Chemicals IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)Medicap Healthcare Ltd.'s revenue increased by 7% and profit after tax (PAT) rose by 11% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)Supreet Chemicals Ltd.'s revenue increased by 52% and profit after tax (PAT) rose by 103% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 98 | 81.26 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 27.30% | 24.51% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 17.67% | 19.61% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.67 | 0.85 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 24.02% | 24.51% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Medicap Healthcare IPO Retail Individual Investors (RII) are offered 0 shares while in Supreet Chemicals IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Medicap Healthcare IPO and 0 shares in Supreet Chemicals IPO.
| Medicap Healthcare IPO | Supreet Chemicals IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 0 shares | 0 shares |
| NII | 0 shares | 0 shares |
| RII | 0 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 0 shares |
Medicap Healthcare IPO subscribed in total, whereas Supreet Chemicals IPO subscribed .